Research theme for competitive and other funds (4)：
2021 - 2024 新規エコーシートによる超音波診断法の確立
2018 - 2021 Development of a liver cancer treatment simulation system and establishment of a remote treatment system
2015 - 2018 Development of multipolar ablation with a three-dimensional simulator system for patients with liver cancer
2014 - 2017 The association between sleep-disordered breathing and prognosis among patients with liver diseases:
Papers (371)：
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, et al. Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver. 2024
Takashi Kumada, Hidenori Toyoda, Sadanobu Ogawa, Tatsuya Gotoh, Yuichi Yoshida, Masahiro Yamahira, Masashi Hirooka, Yohei Koizumi, Yoichi Hiasa, Tsutomu Tamai, et al. Diagnostic performance of shear wave measurement in the detection of hepatic fibrosis: A multicenter prospective study. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Silvia Camera, Margherita Rimini, Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, et al. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma. Targeted oncology. 2024
Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, et al. α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma. International journal of cancer. 2023
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, et al. Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed-effects regression model approach. Cancer medicine. 2023
Masanori Abe, Osamu Yoshida, Takao Watanabe, Kotaro Sunago, Atsushi Yukimoto, Yohei Koizumi, Yoshio Tokumoto, Masashi Hirooka, Yoichi Hiasa. VALIDITY AND RELIABILITY OF PBC-10 IN THE ASSESSMENT OF THE HEALTH-RELATED QOL IN JAPANESE PATIENTS WITH PBC. HEPATOLOGY. 2021. 74. 787A-787A
Yohei Koizumi, Masashi Hirooka, Kotaro Sunago, Atsushi Yukimoto, Takao Watanabe, Osamu Yoshida, Masanori Abe, Yoichi Hiasa. GERIATRIC ASSESSMENT OF ELDERLY PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA PREDICTS WORSENING OF ALBI SCORE WITH MOLECULAR TARGETED THERAPY. HEPATOLOGY. 2021. 74. 644A-644A
Teruki Miyake, Osamu Yoshida, Masanori Abe, Masumi Miyazaki, Hironobu Nakaguchi, Atsushi Yukimoto, Takao Watanabe, Yohei Koizumi, Yoshio Tokumoto, Masashi Hirooka, et al. TRANS-FATTY ACIDS EXACERBATE FAT DEPOSITION IN THE LIVER AND REDUCE FAT ACCUMULATION IN THE VISCERAL ADIPOSE TISSUE BY UPREGULATING GPAM WHICH REGULATES TG RELEASE FROM THE LIVER. HEPATOLOGY. 2021. 74. 1097A-1097A
Atsushi Yukimoto, Takao Watanabe, Yuki Okazaki, Kotaro Sunago, Yoshiko Nakamura, Yohei Koizumi, Osamu Yoshida, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe, et al. THE LONG NON-CODING RNA OF RMRP IS REPRESSED BY ER STRESS AND INDUCES APOPTOSIS IN HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2021. 74. 307A-307A
